Hyperglycemia leads to PKC activation, and increased PKC activity can lead to alterations in the ECM (Sheetz and King, 2002), leading to cardiomyocyte hypertrophy and interstitial fibrosis, PKC activation can also induce mitogen-activated protein kinase (MAPK). This evidence concerns the gene PRRT2 and Hyperglycemia.